Skip to content

Perioperative Endothelial Dysfunction

Perioperative Endothelial Dysfunction in Patients Undergoing Non-cardiac Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02344771
Enrollment
31
Registered
2015-01-26
Start date
2015-03-31
Completion date
2015-06-30
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Injury

Keywords

Endothelial dysfunction, General Surgery, Perioperative Care

Brief summary

More than one in 100 otherwise healthy patients undergoing non-cardiac surgery will die within 30 days post-operatively, and of these patients 45% will die from vascular causes such as myocardial infarction. The pathogenesis of perioperative myocardial infarction is complex and to date not fully elucidated. The physiological stress response associated with the surgical procedure is believed to be central in the development of perioperative cardiovascular complications. Surgery initiates systemic inflammation, hypercoagulability and increases the production of catecholamines and cortisol. These drastic systemic changes lead to a state of myocardial oxygen supply-demand mismatch, which added to acute endothelial dysfunction and ruptures of vulnerable plaques, may result in myocardial injury. The endothelium is a regulator of vascular homeostasis, vascular tone and structure and exerts anticoagulant, antiplatelet and fibrinolytic properties. Endothelial dysfunction is characterized by a decreased vascular bioavailability of nitric oxide probably due to an increased degradation of nitric oxide via its interaction with locally produced reactive oxygen species. No clinical studies have investigated whether peri- and postoperative endothelial dysfunction is associated with an increased risk of perioperative myocardial injury. Endothelial dysfunction may be a key element in the development of perioperative myocardial injury. The aim of this observational clinical study is to closely examine the endothelial function and its dynamics in the early postoperative period.

Interventions

PROCEDUREElective colon cancer surgery

Sponsors

Zealand University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

• Patients scheduled for elective colon cancer surgery

Exclusion criteria

* Not capable of giving informed consent after oral and written information * Previously included in the trial * Surgery within 7 days of the trial

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline endothelial function (reactive hyperemia index) at 4 days postoperativelybaseline before operation, 4 hours postoperatively and daily assessments day 1-4 after surgery.The reactive hyperemia index is assessed non-invasively by the EndoPat system.

Secondary

MeasureTime frame
Biomarkers of endothelial function: plasma arginine, plasma asymmetric dimethylarginine and plasma tetrahydrobiopterinbefore surgery, 4 hours postoperatively and daily assessments on day 1-4 after surgery
Biomarkers of endothelial glycocalyx degradation (syndecan-1, atrial natriuretic peptide)before surgery, 4 hours postoperatively and daily assessments on day 1-4 after surgery.
Plasma cardiac troponin Ibefore surgery and one daily assessment on day 1-4 after surgery.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026